{"name":"Biolab Sanus Farmaceutica","slug":"biolab-sanus-farmaceutica","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Reference Pantogar","genericName":"Reference Pantogar","slug":"reference-pantogar","indication":"Treatment of hair loss and improvement of hair growth","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BL 3000","genericName":"BL 3000","slug":"bl-3000","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Reference Pantogar","genericName":"Reference Pantogar","slug":"reference-pantogar","phase":"phase_3","mechanism":"Pantogar is a combination of vitamins and minerals used to treat hair loss and improve hair growth.","indications":["Treatment of hair loss and improvement of hair growth"],"catalyst":""},{"name":"BL 3000","genericName":"BL 3000","slug":"bl-3000","phase":"phase_3","mechanism":"BL 3000 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOUzh3TlhHa2lDVm9MQU4tWlJzUDBsWlFfcUJtclZRUG1YZ0JmZFRVYnZIMTlVVEZ3R3NzajhGcElicDA4OVZwVkZHYWFxZkJ2eTE3M3BkNGlTOC0zU24yeHBFNmZGOGllZ0lfMFJ6RHBKd2QtQ0tuMFB5MmxKVTloU28yVkVWYWp4dVB2dFEyUlpuZDhXejdNLW1xYWs0S3VWaGRxTlAxN3lfN1l2SUdFbHA1VlQ0bmxuY28wckxSREVpT0hXMTNYbkVZOEVmcDZwcUxFblhZTUJiT3R1dDhoLXBUN19DMkJVU0xnUm1fdGdZUTVKNHVRbkRxcWZvMjlG?oc=5","date":"2025-01-24","type":"pipeline","source":"BioSpace","summary":"Athlete’s Foot Market Size to Reach USD 880.4 Million by 2035, Impelled by Rising Prevalence of Athlete's Foot and Evolving Lifestyles - BioSpace","headline":"Athlete’s Foot Market Size to Reach USD 880.4 Million by 2035, Impelled by Rising Prevalence of Athlete's Foot and Evolv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPOW1xVnZUX2l4VU00RHdmaEtqc01WNFUxdlVPUGFvY2tCY0kycU5EUVY0UnBFZS1Cd1VObWZiN3gxdWhiNmUta3RabExsbFNOVXY2VXo3WmtRMDhrbl9fLUNzeG1Tem5DWlNub0Z3Ukx4SWN4Y0lxeEotY0RYN3RrZ3ZDdENNc2dnT1YybWl0QTFfdw?oc=5","date":"2024-03-08","type":"pipeline","source":"PMLiVE","summary":"Country report: The healthcare market in Brazil - PMLiVE","headline":"Country report: The healthcare market in Brazil","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}